2 months ago
AXGN
AnalystsCaitlin CroninCaitlin Cronin's Stock Forecasts
AnalystsCaitlin Cronin
Analyst Ranking
Bottom 11%
#4343 out of 4868 analysts
Average Return
-11.4%
Win Rate
24%4 out of 17
Risk vs Reward
Poor
Good
Caitlin Cronin's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Axogen IncAXGN | +138.91% | $6.81 | $16.27 | 2024-06-20 - 2025-04-30 | Strong Buy |
Koru Medical Systems IncKRMD | +61.02% | $2.36 | $3.80 | 2023-12-07 - 2024-12-06 | Strong Buy |
Alphatec Holdings IncATEC | +59.13% | $6.90 | $10.98 | 2024-08-30 - 2025-04-30 | Strong Buy |
Alphatec Holdings IncATEC | +1.01% | $10.87 | $10.98 | 2024-07-25 - 2025-04-30 | Strong Buy |
Caitlin Cronin Analyst Color
Get additional color on Caitlin Cronin's coverage of popular stocks
3 months ago
AXGN
Caitlin Cronin's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Inmode LtdINMD | 3 | Hold | $15.00 | +6.38% | Maintains | 3 days ago |
Tela Bio IncTELA | 4 | Strong Buy | $7.00 | +621.65% | Maintains | a month ago |
Smith & Nephew PLCSNN | 1 | Hold | $27.00 | -3.64% | Maintains | a month ago |
Bioventus IncBVS | 1 | Strong Buy | $15.00 | +105.20% | Maintains | a month ago |
Axogen IncAXGN | 3 | Strong Buy | $26.00 | +59.80% | Maintains | 2 months ago |
Vericel CorpVCEL | 3 | Strong Buy | $67.00 | +76.22% | Maintains | 3 months ago |
Koru Medical Systems IncKRMD | 2 | Strong Buy | $4.00 | +45.45% | Maintains | 6 months ago |
Alphatec Holdings IncATEC | 3 | Strong Buy | $20.00 | +82.15% | Maintains | 8 months ago |
Zimmer Biomet Holdings IncZBH | 1 | Hold | $130.00 | N/A | Reiterates | a year ago |
Enovis CorpENOV | 1 | Strong Buy | $75.00 | N/A | Maintains | a year ago |
Vicarious Surgical IncRBOT | 1 | Hold | $12.00 | N/A | Downgrades | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.